Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125867041 | 12586704 | 1 | I | 0 | 20160722 | 20160722 | DIR | 0.00 | F | N | 0.00000 | 20160721 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125867041 | 12586704 | 1 | PS | RECLAST | ZOLEDRONIC ACID | 1 | 1 INJECTION (S) A YEAR | 0 | SUSPENSION FOR INJECTION | ||||||||||
| 125867041 | 12586704 | 3 | C | TARCEVA | ERLOTINIB HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125867041 | 12586704 | 5 | C | CLARITIN | LORATADINE | 1 | 0 | ||||||||||||
| 125867041 | 12586704 | 7 | C | ALBUTEROL. | ALBUTEROL | 1 | 0 | ||||||||||||
| 125867041 | 12586704 | 9 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | 0 | ||||||||||||
| 125867041 | 12586704 | 11 | C | XANAX | ALPRAZOLAM | 1 | 0 | ||||||||||||
| 125867041 | 12586704 | 13 | C | RESTASIS | CYCLOSPORINE | 1 | 0 | ||||||||||||
| 125867041 | 12586704 | 15 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125867041 | 12586704 | 17 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | 0 | ||||||||||||
| 125867041 | 12586704 | 19 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 125867041 | 12586704 | 21 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 125867041 | 12586704 | 23 | C | LOSARTAN. | LOSARTAN | 1 | 0 | ||||||||||||
| 125867041 | 12586704 | 25 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125867041 | 12586704 | 27 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 125867041 | 12586704 | 29 | C | POTASSIUM CHLOIRDE | 2 | 0 | |||||||||||||
| 125867041 | 12586704 | 31 | C | MIRAPEX | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125867041 | 12586704 | 33 | C | ATROVASTATIN | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 125867041 | 12586704 | 35 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 0 | ||||||||||||
| 125867041 | 12586704 | 37 | C | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125867041 | 12586704 | 39 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 125867041 | 12586704 | 41 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | 0 | ||||||||||||
| 125867041 | 12586704 | 43 | C | OXYGEN. | OXYGEN | 1 | 0 | ||||||||||||
| 125867041 | 12586704 | 45 | C | VITAMIN D2 | ERGOCALCIFEROL | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125867041 | 12586704 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125867041 | 12586704 | Chest pain | |
| 125867041 | 12586704 | Dyspnoea | |
| 125867041 | 12586704 | Gait disturbance | |
| 125867041 | 12586704 | Oxygen saturation decreased | |
| 125867041 | 12586704 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |